Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:41,950Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:-41,950Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-1,500Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-1,500Price:--
-
Feb 22, 2024 (filed on Feb 26, 2024)Insider Name:Macino JeanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,130Price:$253.42
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:375Price:$52.69
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-438Price:$260.00
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:438Price:$79.49
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-400Price:$260.89
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-504Price:$260.89
Filings by filing date
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:41,950Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:-41,950Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-1,500Price:--
-
Mar 13, 2024 (filed on Mar 15, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-1,500Price:--
-
Feb 22, 2024 (filed on Feb 26, 2024)Insider Name:Macino JeanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,130Price:$253.42
-
Feb 21, 2024 (filed on Feb 23, 2024)Insider Name:Clemons V GordonOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,000Price:$264.00
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:375Price:$52.69
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-438Price:$260.00
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:438Price:$79.49
-
Feb 21, 2024 (filed on Feb 22, 2024)Insider Name:O'Brien BrandonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-400Price:$260.89
News
Biz Brief
Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | SUITE 1020, 2010 MAIN STREE IRVINE CA 92614 |
Tel: | N/A |
Website: | https://www.corvel.com |
IR: | See website |
Key People | ||
V. Gordon Clemons Chairman of the Board | Michael G. Combs President, Chief Executive Officer | Brandon T. O'Brien Chief Financial Officer |
Mark E. Bertels Executive Vice President - Risk Management Services | Maxim Shishin Chief Information Officer | Jennifer L. Yoss Vice President - Accounting |
Jeff Gurtcheff Chief Claims Officer | Richard J. Schweppe Secretary |
Business Overview |
CorVel Corporation is engaged in applying technology, including artificial intelligence, machine learning, and natural language processing designed to address the management of episodes of care and the related health-care costs. The Company's services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and Medicare services. It partners with employers, third party administrators (TPAs), insurance companies, and government agencies to assist its customers in managing the medical costs of workers compensation, group health, and auto insurance and in monitoring the quality of care provided to claimants. Its network solutions services include professional nurse review, expert fee negotiations, specialty networks, preferred provider organization management, medical bill repricing, automated adjudication, and electronic reimbursement. Its bill review services include coding review and re-bundling. |
Financial Overview |
For the nine months ended 31 December 2023, CorVel Corp revenues increased 10% to $588.1M. Net income increased 18% to $56.8M. Revenues reflect Patient management Services segment increase from $118.9M to $389.4M, Network Solution Services segment increase from $60.5M to $198.7M. Net income benefited from Stock-based Compensation in SGA decrease of 25% to $1.6M (expense). |
Employees: | 4,444 as of Mar 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $4,314M as of Dec 31, 2023 |
Annual revenue (TTM): | $773.52M as of Dec 31, 2023 |
EBITDA (TTM): | $120.92M as of Dec 31, 2023 |
Net annual income (TTM): | $74.97M as of Dec 31, 2023 |
Free cash flow (TTM): | $70.43M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 17,094,277 as of Jan 29, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |